Medical Review Panel
A distinguished panel of rheumatology experts collaborated in the development of the Arthritis Today Drug Guide and is consulted on an ongoing basis for updates.
The information contained in this Guide is based on a combination of these experts’ own clinical experiences and expertise, as well as on U.S. Pharmacopeia Dispensing Information (US PDI) and package inserts.
ERIC L. MATTESON, MD, MPH, Professor of Medicine and Chair, Division of Rheumatology, Mayo Clinic, Rochester, Minn., reviewed the sections on biologics and disease-modifying anti-rheumatic drugs (DMARDs).
DONALD MILLER, PharmD, Professor and Chair, Department of Pharmacy Practice, North Dakota State University, Fargo, N.D., reviewed the sections on nonsteroidal anti-inflammatory drugs (NSAIDs) and analgesics.
JAMES ROSENBAUM, MD, Edward E. Rosenbaum Professor of Inflammatory Diseases, Division Chief, Arthritis and Rheumatic Diseases, and Head, Uveitis Clinic, Oregon Health & Science University; Chenoweth Chair of Ophthalmology, Legacy Devers Eye Clinic, Portland, Ore., reviewed the section on Sjögren’s syndrome.
KENNETH SAAG, MD, Lowe Professor and Director, Center for Education and Research on Therapeutics of Musculoskeletal Disorders and Center for Outcomes Effectiveness Research and Education, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Ala., reviewed the sections on corticosteroids, osteoporosis and gout.
ARIEL D. TEITEL, MD, Clinical Associate Professor of Medicine, New York University Langone Medical Center, New York City, reviewed the section on fibromyalgia.
The Arthritis Today Drug Guide is meant for education – not self-medicating. Arthritis Today, the Arthritis Foundation and the Drug Guide Medical Review Panel do not endorse any products mentioned in this guide. While we endeavor to keep the information up to date, we make no representations or warranties about the completeness of the information provided.